Indication
Preclinical
Ph.1
Ph.2a
Ph.2b
Ph.3
Postoperative Tissue Fibrosis
TTX333
OB-GYN
General
Surgery
Endometriosis
TTX334e
Endometriosis
Oncology
TTX335o
Ovarian
Cancer
Indication
Proof op Concept & Feasibility
Design & Verification
Pivotal
Companion Diagnostic Biomarker-FDA 510K (De-Novo) & EMA CE-IVD
TTX334Dx
Endometriosis
TTX335Dx
Ovarian Cancer
Endometriosis –Lab Developed Test (Early Screen)
Indication
Proof op Concept & Feasibility
Design & Verification
Pivotal
Endometriosis